SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-18-005539
Filing Date
2018-08-09
Accepted
2018-08-09 16:06:33
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 a2236429z424b5.htm 424B5 129442
2 G559309.JPG g559309.jpg GRAPHIC 18224
3 G684570.JPG g684570.jpg GRAPHIC 3772
  Complete submission text file 0001047469-18-005539.txt   160997
Mailing Address 2530 MERIDIAN PARKWAY SUITE 300 DURHAM NC 27713
Business Address 2530 MERIDIAN PARKWAY SUITE 300 DURHAM NC 27713 919-806-4487
Dova Pharmaceuticals, Inc. (Filer) CIK: 0001685071 (see all company filings)

IRS No.: 813858961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-226403 | Film No.: 181005043
SIC: 2834 Pharmaceutical Preparations